Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Microbial Biosensors01:17

Microbial Biosensors

Microbial biosensors are analytical devices that utilize living microbes to detect specific substances through measurable signals. These devices consist of two main components: biosensing organisms and signal-transducing elements. Biosensing organisms, such as Escherichia coli or Saccharomyces cerevisiae, are typically housed in multiwell plates connected to transducers, enabling rapid, real-time detection of target analytes.Signal Generation MechanismWhen a target analyte—such as...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neural Melanocortin Receptors in Fish: Insights into Growth Regulation and Aquaculture Advancement.

Biomolecules·2026
Same author

July 2026 issue first authors.

Trends in pharmacological sciences·2026
Same author

Nutrition, Metabolism, and Physiology in Aquatic Animals: Current Advances and Future Directions.

Metabolites·2026
Same author

Association of Mutations in the <i>Melanocortin-2 Receptor Accessory Protein 2</i> Gene (<i>MRAP2</i>) and Obesity: A Systematic Review and Meta-Analysis.

International journal of molecular sciences·2026
Same author

Beyond G protein and arrestin: GRK2-biased β₂AR signaling.

Trends in pharmacological sciences·2025
Same author

Atrazine's effects on mammalian physiology.

Journal of toxicology and environmental health. Part B, Critical reviews·2025

Related Experiment Video

Updated: Jun 14, 2026

BRET-based G Protein Biosensors for Measuring G Protein-Coupled Receptor Activity in Live Cells
09:21

BRET-based G Protein Biosensors for Measuring G Protein-Coupled Receptor Activity in Live Cells

Published on: November 7, 2025

Biosensors for translatable GPCR bias.

Ren-Lei Ji1, Ya-Xiong Tao1

  • 1Department of Anatomy, Physiology and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA.

Trends in Pharmacological Sciences
|June 12, 2026
PubMed
Summary

Biased agonism in G protein-coupled receptors (GPCRs) shows promise for better drug efficacy and safety. New biosensors offer detailed mechanistic insights, transforming bias from a simple label into graded pharmacological evidence.

Keywords:
G proteinsGPCR biosensorsbiased agonismcompartmentalized signalingdrug discoveryβ-arrestin

More Related Videos

A "Dual-Addition" Calcium Fluorescence Assay for the High-Throughput Screening of Recombinant G Protein-Coupled Receptors
08:46

A "Dual-Addition" Calcium Fluorescence Assay for the High-Throughput Screening of Recombinant G Protein-Coupled Receptors

Published on: December 2, 2022

Monitoring GPCR-&#946;-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
08:21

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery

Published on: June 28, 2019

Related Experiment Videos

Last Updated: Jun 14, 2026

BRET-based G Protein Biosensors for Measuring G Protein-Coupled Receptor Activity in Live Cells
09:21

BRET-based G Protein Biosensors for Measuring G Protein-Coupled Receptor Activity in Live Cells

Published on: November 7, 2025

A "Dual-Addition" Calcium Fluorescence Assay for the High-Throughput Screening of Recombinant G Protein-Coupled Receptors
08:46

A "Dual-Addition" Calcium Fluorescence Assay for the High-Throughput Screening of Recombinant G Protein-Coupled Receptors

Published on: December 2, 2022

Monitoring GPCR-&#946;-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
08:21

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery

Published on: June 28, 2019

Area of Science:

  • Pharmacology
  • Biochemistry
  • Molecular Biology

Background:

  • Biased agonism at G protein-coupled receptors (GPCRs) is a strategy to enhance drug efficacy and safety.
  • Current translation is hindered by assay-dependent selectivity definitions.
  • Older assays often fail to capture complex signaling events.

Purpose of the Study:

  • To discuss how advanced biosensors can provide a mechanistic understanding of GPCR signaling.
  • To highlight the role of biosensors in overcoming limitations of traditional assays.
  • To propose a shift in viewing receptor bias as graded evidence.

Main Methods:

  • Utilizing recent biosensor technologies to resolve GPCR signaling across multiple mechanistic layers.
  • Employing open, scalable platforms for comparative profiling.
  • Leveraging orthogonal, unimolecular, and endogenous-compatible systems for mechanistic attribution.

Main Results:

  • Biosensors capture detailed GPCR signaling dynamics, including conformational changes, G protein coupling, and β-arrestin engagement.
  • New platforms allow for comprehensive profiling and mechanistic insights.
  • These advances support a graded view of receptor bias.

Conclusions:

  • Biosensors provide a more nuanced understanding of GPCR biased agonism.
  • The data generated by biosensors convert assay-specific findings into translatable pharmacological evidence.
  • Receptor bias should be interpreted as a spectrum rather than a binary characteristic.